Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living\u202fwith neurodegenerative diseases. Our goal is to modify the course of these diseases and improve quality of life. Our lead asset, ATH434, has the potential to treat vari...See more
Headquarter Australia |
Countries of operation Australia |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Chairman
Senior Principal Research Scientist